IBDEI0I7 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8510,0)
 ;;=V12.01^^35^485^54
 ;;^UTILITY(U,$J,358.3,8510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8510,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,8510,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,8510,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,8511,0)
 ;;=V13.01^^35^485^36
 ;;^UTILITY(U,$J,358.3,8511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8511,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,8511,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,8511,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,8512,0)
 ;;=V12.51^^35^485^59
 ;;^UTILITY(U,$J,358.3,8512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8512,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,8512,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,8512,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,8513,0)
 ;;=V17.89^^35^485^18
 ;;^UTILITY(U,$J,358.3,8513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8513,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,8513,1,5,0)
 ;;=5^Family h/o Musculosk Disease
 ;;^UTILITY(U,$J,358.3,8513,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,8514,0)
 ;;=V12.54^^35^485^56
 ;;^UTILITY(U,$J,358.3,8514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8514,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,8514,1,5,0)
 ;;=5^Hx of TIA
 ;;^UTILITY(U,$J,358.3,8514,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,8515,0)
 ;;=V12.54^^35^485^52
 ;;^UTILITY(U,$J,358.3,8515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8515,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,8515,1,5,0)
 ;;=5^Hx of Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,8515,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,8516,0)
 ;;=V15.88^^35^485^33
 ;;^UTILITY(U,$J,358.3,8516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8516,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,8516,1,5,0)
 ;;=5^Hx of Fall(s)
 ;;^UTILITY(U,$J,358.3,8516,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,8517,0)
 ;;=V13.59^^35^485^42
 ;;^UTILITY(U,$J,358.3,8517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8517,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,8517,1,5,0)
 ;;=5^Hx of Musculosk Disease
 ;;^UTILITY(U,$J,358.3,8517,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,8518,0)
 ;;=V15.52^^35^485^55
 ;;^UTILITY(U,$J,358.3,8518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8518,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,8518,1,5,0)
 ;;=5^Hx of TBI
 ;;^UTILITY(U,$J,358.3,8518,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,8519,0)
 ;;=V12.04^^35^485^38
 ;;^UTILITY(U,$J,358.3,8519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8519,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,8519,1,5,0)
 ;;=5^Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,8519,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,8520,0)
 ;;=V13.51^^35^485^23
 ;;^UTILITY(U,$J,358.3,8520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8520,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,8520,1,5,0)
 ;;=5^Hs of Pathological Fx
 ;;^UTILITY(U,$J,358.3,8520,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,8521,0)
 ;;=V15.51^^35^485^58
 ;;^UTILITY(U,$J,358.3,8521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8521,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,8521,1,5,0)
 ;;=5^Hx of Traumatic Fx
 ;;^UTILITY(U,$J,358.3,8521,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,8522,0)
 ;;=V62.22^^35^485^49
 ;;^UTILITY(U,$J,358.3,8522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8522,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,8522,1,5,0)
 ;;=5^Hx of Return from Military Deployment
 ;;^UTILITY(U,$J,358.3,8522,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,8523,0)
 ;;=919.1^^35^486^1
 ;;^UTILITY(U,$J,358.3,8523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8523,1,4,0)
 ;;=4^919.1
 ;;^UTILITY(U,$J,358.3,8523,1,5,0)
 ;;=5^Abrasion, Infected
 ;;
 ;;$END ROU IBDEI0I7
